-
Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
Author: Lin, Cai-Jin; Xiao, Wen-Xuan; Fu, Tong; Jin, Xi; Shao, Zhi-Ming; Di, Gen-Hong
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00531-4
-
Phase I study of A166, an antibody-drug conjugate in advanced HER2-expressing solid tumours
Author: Zhang, Jian; Liu, Rujiao; Gao, Shuiping; Li, Wenhua; Chen, Yang; Meng, Yanchun; Liu, Chang; Jin, Wenyue; Wu, Junyan; Wang, Ying; Hao, Yanrong; Yi, Shuli; Qing, Yan; Ge, Junyou; Hu, Xichun
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00522-5
-
The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
Author: Zhou, Danyang; Li, Mei; Yasin, Mohamed Hussein; Lu, Qianyi; Fu, Jia; Jiang, Kuikui; Hong, Ruoxi; Wang, Shusen; Xu, Fei
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00527-0
-
Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
Author: Zhu, Ying; Liu, Zhixian; Gui, Liang; Yun, Wen; Mao, Changfei; Deng, Rong; Yao, Yufeng; Yu, Qiao; Feng, Jifeng; Ma, Hongxia; Bao, Wei
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00540-3
-
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer
Author: Yang, Ziyan; Feng, Jianguo; Jing, Ji; Huang, Yuan; Ye, Wei-Wu; Lei, Lei; Wang, Xiao-Jia; Cao, Wen-Ming
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00542-1
-
Predicting breast cancer types on and beyond molecular level in a multi-modal fashion
Author: Zhang, Tianyu; Tan, Tao; Han, Luyi; Appelman, Linda; Veltman, Jeroen; Wessels, Ronni; Duvivier, Katya M.; Loo, Claudette; Gao, Yuan; Wang, Xin; Horlings, Hugo M.; Beets-Tan, Regina G. H.; Mann, Ritse M.
Journal: NPJ BREAST CANCER. 2023; Vol. 9, Issue 1, pp. -. DOI: 10.1038/s41523-023-00517-2
